Promiscuity behind pain drug trial death for BIS-102474
BioWorld Online
LONDON – New in vitro research in human brain cells has identified off-target effects that may have caused the death of a volunteer, and neurological damage in four others, in the phase I trial of BIA-102474. Using proteomic methods to determine all